CD8A and neoplasm: Tumor cells such as HLA-E and immune cells such as CD8 and NK cells can express immune checkpoint molecules upon exposure to immune factors such as cytokines, which prevent NK and CD8 cell activation, even resulting in NK and CD8 cell dysfunction or exhaustion (Figure 4).